Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Clin Oncol ; 27(22): 3620-6, 2009 Aug 01.
Article in English | MEDLINE | ID: mdl-19487378

ABSTRACT

PURPOSE: For nearly two decades, multiple retrospective reports, small prospective studies, and meta-analyses have arrived at conflicting results regarding the value of timing surgical intervention for breast cancer on the basis of menstrual cycle phase. We present the results of a multi-cooperative group, prospective, observational trial of menstrual cycle phase and outcome after breast cancer surgery, led by the North Central Cancer Treatment Group (NCCTG) in collaboration with the National Surgical Adjuvant Breast and Bowel Project (NSABP) and the International Breast Cancer Study Group (IBCSG). PATIENTS AND METHODS: Premenopausal women age 18 to 55 years, who were interviewed for menstrual history and who were surgically treated for stages I to II breast cancer, had serum drawn within 1 day of surgery for estradiol, progesterone, and luteinizing hormone levels. Menstrual history and hormone levels were used to determine menstrual phase: luteal, follicular, and other. Disease-free survival (DFS) and overall survival (OS) rates were determined by Kaplan-Meier method and were compared by using the log-rank test and Cox proportional hazard modeling. RESULTS: Of 1,118 women initially enrolled, 834 women comprised the study cohort: 230 (28%) in luteal phase; 363 (44%) in follicular phase; and 241 grouped as other. During a median follow-up of 6.6 years, and in analysis that accounted for nodal disease, estrogen receptor status, adjuvant radiation therapy or chemotherapy, neither DFS nor OS differed with respect to menstrual phase. The 5-year DFS rates were 82.7%, 82.1%, and 79.2% for follicular, luteal, or other phases, respectively. Corresponding OS survival rates were 91.9%, 92.2%, and 91.8%, respectively. CONCLUSION: When menstrual cycle phases were strictly defined, neither DFS nor OS differed between women who underwent surgery during the follicular phase versus the luteal phase. Nearly 30% of the patients did not meet criteria for either follicular- or luteal-phase categories.


Subject(s)
Breast Neoplasms/mortality , Breast Neoplasms/surgery , Follicular Phase/blood , Luteal Phase/blood , Mastectomy/methods , Adult , Analysis of Variance , Breast Neoplasms/blood , Breast Neoplasms/pathology , Disease-Free Survival , Follow-Up Studies , Humans , Kaplan-Meier Estimate , Male , Mastectomy/mortality , Menstrual Cycle/blood , Middle Aged , Neoplasm Staging , Premenopause , Preoperative Care/methods , Probability , Proportional Hazards Models , Prospective Studies , Risk Assessment , Statistics, Nonparametric , Survival Rate , Time Factors , Treatment Outcome , Young Adult
2.
Pathology ; 35(2): 109-19, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12745457

ABSTRACT

AIM: Granulomatous mastitis is a rare condition of unknown aetiology. The great majority of cases has not been associated with bacterial pathogens if women with mammary tuberculosis are excluded. We noted that some women in Auckland with a histological diagnosis of granulomatous mastitis had both microbiological and histological evidence of corynebacteria infection and aimed to study this further. METHODS: Thirty-four women were reviewed who presented with inflammatory breast disease and had microbiological specimens from which corynebacteria were isolated and/or histological specimens containing coryneform bacteria. These 34 cases were compared with 28 controls with similar histology but no evidence of corynebacteria infection. RESULTS: Twenty-seven (79%) of the cases and 21 (75%) of the controls had histological and/or cytological evidence of suppurative granulomas. Fourteen of the 34 cases also had Gram-positive bacilli (GPB), recognisable as coryneform bacteria, in histological sections. In all cases the bacilli were confined to empty spaces, consistent with dissolved lipid, and were surrounded by neutrophils and, frequently, suppurative granulomas. Corynebacterium species were isolated from 52 of 116 microbiological specimens taken from the 34 cases. Forty of these 52 cultures were pure. Twenty-four of the cultures were further classified biochemically and using 16S rRNA gene sequencing. Twenty of the 24 were lipophilic Corynebacterium species and 14 were identified as Corynebacterium kroppenstedtii. The cases were more likely to present with fever or neutrophilia and more often formed sinuses than the controls but other clinical features were similar. Maori and Pacific Islanders accounted for 77% of the women across both groups. CONCLUSION: We suggest granulomatous mastitis can be associated with corynebacteria infection, particularly infection by C. kroppenstedtii. The significance of this finding, which has previously been described in only a single case report, is discussed.


Subject(s)
Corynebacterium Infections/pathology , Corynebacterium/isolation & purification , Granuloma/pathology , Mastitis/pathology , Adult , Corynebacterium/classification , Corynebacterium/genetics , Corynebacterium Infections/complications , Corynebacterium Infections/ethnology , Female , Genes, Bacterial , Granuloma/ethnology , Granuloma/microbiology , Humans , Mastitis/ethnology , Mastitis/microbiology , Native Hawaiian or Other Pacific Islander , New Zealand/epidemiology , RNA, Bacterial/analysis , RNA, Ribosomal, 16S/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...